1 Feb 2017

Transparency notifications

Read More
24 Jan 2017

Transparency notifications

Read More
19 Jan 2017

Final CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Primary Efficacy Endpoint in Patients with Moderate-to-Severe Chronic Plaque Psoriasis

Read More
19 Jan 2017

UCB files BRIVIACT® (brivaracetam) CV in the U.S. as monotherapy treatment for adult epilepsy patients with partial-onset seizures

Read More
16 Jan 2017

Transparency notification

Read More
12 Jan 2017

Transparency notification

Read More
9 Jan 2017

Transparency notification

Read More
9 Jan 2017

Transparency Notification

Read More
30 Dec 2016

Transparency notification

Read More
23 Dec 2016

Transparency notification

Read More
Subscribe to